ACRO Biomedical Co Ltd Sustainability Reports
ACRO Biomedical Co., Ltd. develops and manufactures medical-grade regenerative biomaterials derived from animal tissue. Its product pipeline specializes in human tissue engineering, regenerative medicine, wound care, orthopedics, dentistry, and ophthalmology.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG00BCHW213
4 reports from 2019 to 2024